Skip to main content
BNTC logo
BNTC
(NASDAQ)
Benitec Biopharma Inc.
$10.92-- (--)
Loading... - Market loading

Benitec Biopharma (BNTC) Stock Price & Financial Analysis

Benitec Biopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.57 - $11.02
52-Week High$17.15
52-Week Low$9.85
Open$10.73
Volume53.61K
Average Volume (3M)53.61K
Market Cap502.00M
Shares Outstanding45.97M
Price to Sales (P/S)907.01
Price to Book (P/B)2.69
EV/EBITDA-6.32
Revenue (TTM)556.00K
Net Income (TTM)-46.30M
Free Cash Flow (TTM)-18.44M
EPS (TTM)$-1.01
Profit Margin-8327.88%
Operating Margin-9090.65%
Return on Equity (ROE)-24.71%
Debt to Equity0.01
50-Day MA$11.46
200-Day MA$12.79
52-Week Change-8.74%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJun 1, 2018

Frequently Asked Questions About Benitec Biopharma

What is the current stock price for BNTC?

As of the latest trading session, BNTC stock trades at $10.92. The 52-week range is $9.85–$17.15, with a day range of $10.57–$11.02.

What is the P/E ratio for BNTC?

The P/E ratio (Price-to-Earnings) for BNTC is shown in the Key Statistics section. This valuation metric helps compare Benitec Biopharma Inc. to industry peers.

Does BNTC pay dividends?

Benitec Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BNTC?

Based on 1 analyst, the consensus for BNTC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BNTC?

Benitec Biopharma's market capitalization is $502.0M, classifying it as a small-cap company. Benitec Biopharma operates in the Healthcare sector within the Biotechnology industry.